KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bionano Genomics (BNGO) Operating Leases (2021 - 2025)

Historic Operating Leases for Bionano Genomics (BNGO) over the last 5 years, with Q3 2025 value amounting to $3.6 million.

  • Bionano Genomics' Operating Leases fell 168.2% to $3.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.6 million, marking a year-over-year decrease of 168.2%. This contributed to the annual value of $145000.0 for FY2024, which is 9596.1% down from last year.
  • As of Q3 2025, Bionano Genomics' Operating Leases stood at $3.6 million, which was down 168.2% from $4.1 million recorded in Q2 2025.
  • Over the past 5 years, Bionano Genomics' Operating Leases peaked at $7.3 million during Q1 2023, and registered a low of $145000.0 during Q4 2024.
  • In the last 5 years, Bionano Genomics' Operating Leases had a median value of $5.1 million in 2021 and averaged $4.9 million.
  • Per our database at Business Quant, Bionano Genomics' Operating Leases soared by 408.47% in 2022 and then tumbled by 9596.1% in 2024.
  • Over the past 5 years, Bionano Genomics' Operating Leases (Quarter) stood at $5.3 million in 2021, then grew by 4.08% to $5.5 million in 2022, then plummeted by 34.77% to $3.6 million in 2023, then plummeted by 95.96% to $145000.0 in 2024, then soared by 2399.31% to $3.6 million in 2025.
  • Its Operating Leases stands at $3.6 million for Q3 2025, versus $4.1 million for Q2 2025 and $1.6 million for Q1 2025.